Skip to content Skip to footer
Subscribe Now

CXO TALKS

CXO Talks: Vikas Sharma Reveals QurAlis’ Bold Vision for the Future of Neuroscience 
In this episode of CXO Talks, PharmaShots speaks with Vikas Sharma, Chief Business Officer at QurAlis, a biotech company leading the development of precision medicines for neurodegenerative diseases  Vikas discusses the company’s FlexASO platform, a next-generation RNA-targeting technology that tackles the root causes of neurological diseases  Vikas also highlights QurAlis’ lead candidates, QRL-201 and QRL-101,…
3 days ago
Rick Modi from Affinia Therapeutics in a Stirring Dialogue Exchange with PharmaShots
CXO Talks: Rick Modi from Affinia Therapeutics in a Stirring Dialogue Exchange with PharmaShots
Shots: In this episode of the CXO Talks podcast, PharmaShots speaks with Rick Modi, CEO at Affinia Therapeutics Driven by cutting-edge innovation, Affinia is pioneering and re-imagining adeno-associated virus serotype 9 (AAV9), a gene therapy delivery method for conditions affecting cardiac muscle, skeletal muscle, and the central nervous system Rick articulates the diagnostic and therapeutic…
September 8, 2025
CXO Talks: Thomas Chalberg & Annahita Keravala from Genascence in a Candid Conversation with PharmaShots
Shots: PharmaShots speaks with Thomas Chalberg, Founder and CEO of Genascence Corporation, and Annahita Keravala, Founder and CSO of Genascence Corporation Thomas and Annahita speak eloquently about Genascence's current lead program, GNSC-001, for osteoarthritis of the knee, and shed light on the unmet medical needs in the disease The duo highlighted the safety and tolerability…
August 11, 2025
CXO Talks: Tim O’Connell from Emtelligent in a Striking Conversation with PharmaShots
CXO Talks: Tim O’Connell from Emtelligent in a Striking Conversation with PharmaShots
Shots:  In this episode of the CXO Talks podcast, PharmaShots spoke with Tim O’Connell, CEO of Emtelligent, a next-generation medical AI company  Tim highlights Emtelligent’s inspiring journey to becoming a leader in a clinical-grade NLP company focused on transforming unstructured data to actionable insights at an enterprise scale  Emtelligent leverages the power of medical records…
June 9, 2025
Spotlight_Barbara Albientz
Reuters Pharma 2025: Post-Conference Talks Featuring Barbara Albientz
Barbara Albientz, Chief Commercialization Officer, Helvion Pharmaceuticals, joins PharmaShots’ Managing Editor Himanshu Sehgal for a riveting dialogue exchange. Barbara shares her experience from the recently held Reuters Events Pharma 2025, where she joined as an affirmative team member for the debate Reality Check: Is Omnichannel Actually Working? Barbara believes AI will be crucial in segmenting…
May 1, 2025
Spotlight_Michael Bierl
Reuters Pharma 2025: Post-Conference Talks Featuring Michael Bierl
Michael Bierl, VP, Partnerships and GM at Flatiron Health, joins PharmaShots’ Managing Editor Himanshu Sehgal for an illuminating dialogue exchange. Michael shares his experience from the recently held Reuters Events Pharma 2025, where he joined as a presenter for the case study titled Bridging gaps: Leverage data, tech and RWE for enhanced healthcare access and…
May 1, 2025
Spotlight_Jayasree Iyer
Reuters Pharma 2025: Post Conference Talks Featuring Jayasree K. Iyer 
Jayasree K. Iyer, CEO of Access to Medicine Foundation, moderated a panel discussion that featured leaders from the 2024 Access to Medicine Index. Jayasree highlighted how biopharma companies foster accessibility to essential medicines in low- and middle-income countries through global partnerships, innovation, and sustainable models. Jayasree talks about the future of Health Equity amidst the…
April 29, 2025
Spotlight Interview_Hector De La Riva
Reuters Pharma 2025: Post-Conference Talks Featuring Hector De La Riva
Hector De La Riva joins PharmaShots Managing Editor Himanshu Sehgal for a riveting conversation on his recent panel discussion at Reuters Events Pharma 2025. “Reimagine Your 2025 Sales Strategy,” the topic of his panel discussion, examined the ever-evolving commercial landscape and the role of field engagement and customer empowerment in shaping strategic investments. Hector stresses…
April 22, 2025
Load more